If you have been monitoring the latest beauty breakthroughs, you have likely noticed that PDRN in skincare is everywhere right now. Often marketed under the catchy name “Salmon DNA,” this ingredient has transitioned from injectable medical treatments to high-performance topical formulations.
But as a formulator, you need to look past the marketing. What is this molecule exactly? Is it just another humectant, or is it truly the next frontier in regenerative beauty? Let’s dive into the science, the mechanism, and the formulation reality of PDRN.
Table of Contents
What Exactly is PDRN?
PDRN stands for Polydeoxyribonucleotide.
It is a mixture of low-molecular-weight DNA fragments. While traditional animal-derived PDRN typically ranges from 50 to 2000 base pairs, next-generation vegan alternatives are engineered to be much smaller.
Historically, PDRN is extracted and purified from the milt (sperm) of Salmon (Oncorhynchus keta) or Trout (Oncorhynchus mykiss).
The reason salmon is used isn’t just marketing; salmon DNA has a high degree of structural similarity to human DNA, making it highly biocompatible and less likely to trigger immune responses.
The Shift to Vegan & Microbial PDRN
While “Salmon DNA” is the origin story, the industry is evolving. Today, formulators have access to:
- Microbial PDRN (e.g., Lacto-PDRN): Produced via fermentation of probiotics like Lactobacillus rhamnosus.
- Plant-Derived PDRN (Phyto-PDRN): Extracted from sources like Barley sprouts or Artemisia capillaris.
- Biosynthetic PDRN: Recombinant DNA produced through engineered microorganisms.
These alternatives offer sustainability, vegan compliance, and significantly lower molecular weights for deeper and faster skin penetration. For instance, plant-derived Phyto-PDRNs typically range from 50 to 500 base pairs, while some microbial Lacto-PDRNs are formulated at under 100 base pairs, allowing them to be up to 8 times lighter at the molecular level than conventional Salmon PDRN.
How Does It Work? The “Salvage Pathway”
PDRN does not work like a traditional antioxidant or acid. It functions as a cell-signaling molecule.
- Adenosine A2A Receptor Activation: PDRN binds to specific receptors on the cell surface. This triggers a cascade that reduces inflammation and stimulates fibroblasts; the cells responsible for collagen and elastin production.
- The Salvage Pathway: To repair or divide, cells need to synthesize DNA. They can do this from scratch (energy-intensive) or via the “Salvage Pathway” by reusing existing nucleotides. PDRN provides these “pre-built” building blocks, allowing the skin to repair itself faster and more efficiently with less metabolic energy.
Is PDRN a “Retinol Rival”?
It is more of a complement than a rival.
- Retinol works by accelerating cell turnover and can be irritating.
- PDRN works by biological repair and soothing.
In fact, PDRN is an excellent ingredient to use alongside retinoids to mitigate irritation and support the skin barrier during the renewal process.
Formulator’s Guide: Technical Specs
If you are looking to add PDRN to your next serum or cream, here is what you need to know:
1. Identifying the INCI
Depending on your supplier and source, you will see different INCI names. Check your TDS (Technical Data Sheet) carefully:
- Sodium DNA: The most common INCI for purified PDRN salts.
- Hydrolyzed DNA: Often used for plant-derived or enzymatically broken down DNA fragments.
- Lactobacillus Ferment / Sodium DNA: For microbial-derived versions.
2. Solubility and Stability
- Solubility: Highly water-soluble.
- pH Range: Stable in a wide range (typically pH 5.0 – 9.0), making it compatible with most skin-neutral formulations.
- Temperature Tolerance: Interestingly, PDRN is highly heat-resistant. In fact, it is extracted and purified at very high temperatures to ensure >95% purity and eliminate any active proteins or peptides. However, in cosmetic manufacturing, it is still recommended to incorporate it during the cooling phase (below 40°C) to maintain the overall stability of the final formulation.
3. Recommended Dosage
While it depends on the concentration of the raw material (liquid vs. powder), the active PDRN concentration in finished products is typically:
- Preventative/Daily Care: 0.01% – 0.1%
- Intensive Repair/Post-Procedure: 0.5% – 3%
Is PDRN Accessible for Small Labs?
While PDRN was once a gatekept medical ingredient, it is becoming increasingly accessible to independent formulators. The rise of liquid PDRN solutions (pre-solubilized in water or butylene glycol) has made it much easier to incorporate into small-batch productions without specialized high-shear equipment.
Final Verdict
PDRN is more than just a trend. It represents a shift toward Regenerative Skincare; products that don’t just “cover up” signs of aging but provide the biological tools for the skin to heal itself. Whether you choose the traditional salmon-derived route or the new wave of vegan microbial PDRN, this is an ingredient that offers genuine, science-backed results for tissue repair and anti-aging.
Further Reading & Scientific References
For formulators and skin care professionals looking to dive deeper into the clinical data, molecular mechanisms, and regenerative properties of PDRN, the following peer-reviewed articles are highly recommended:
1. Akaberi, S. M., et al. (2025). “Polydeoxyribonucleotide in Skincare and Cosmetics: Mechanisms, Therapeutic Applications, and Advancements Beyond Wound Healing and Anti-aging.” *Journal of Skin and Stem Cell*, 12(1): e159728. DOI: https://doi.org/10.5812/jssc-159728
2. Park, S., et al. (2025). “Polydeoxyribonucleotides as Emerging Therapeutics for Skin Diseases: Clinical Applications, Pharmacological Effects, Molecular Mechanisms, and Potential Modes of Action.” *Applied Sciences*, 15(19), 10437. DOI: https://doi.org/10.3390/app151910437
3. Oh, N., et al. (2025). “Versatile and Marvelous Potentials of Polydeoxyribonucleotide for Tissue Engineering and Regeneration.” *Biomaterials Research*, 29, Article 0183. DOI: https://doi.org/10.34133/bmr.0183
4. Squadrito, F., et al. (2017). “Pharmacological Activity and Clinical Use of PDRN.” *Frontiers in Pharmacology*, 8, 224. DOI: https://doi.org/10.3389/fphar.2017.00224
